More recent findings emphasize the key role of nucleotide‐binding domain, leucine‐rich containing family, pyrin domain‐containing‐3 (NLRP3)/IL‐1β signaling in inducing the expansion of PMN‐MDSCs and subsequent suppression of anti‐tumor immunity in cutaneous melanoma.10 Here, IL1B is linked to cutaneous melanoma.